immuno-oncology assays market: Trends, Strategy, Application Analysis, Demand, Status and Global Share

The global immuno-oncology assays market is projected to reach USD 7.9 billion by 2026 from USD 4.4 billion in 2021, at a CAGR of 12.5% during the forecast period. Market growth is driven by factors such as the growing significance of companion diagnostics in drug development and rising incidence of cancer and growing adoption of targeted therapies. On the other hand, the requirement of high capital investments and low cost-benefit ratio and the unfavorable regulatory and reimbursement scenario are the major factors hampering the growth of this market.

Request for FREE PDF Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=1943305

Lists of Companies Profiled in the Report:

  • Thermo Fisher Scientific, Inc. (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Agilent Technologies, Inc. (US)
  • Illumina, Inc. (US)
  • NanoString Technologies, Inc. (US)
  • Sartorius AG (Germany)
  • HTG Molecular Diagnostics, Inc. (US)
  • QIAGEN N.V. (Netherlands)
  • Merck Millipore (US)
  • PerkinElmer, Inc. (US)
  • Abbott Laboratories, Inc. (US)
  • Guardant Health, Inc. (US)
  • bioMérieux SA (France)
  • Myriad Genetics, Inc. (US)
  • MESO SCALE DIAGNOSTICS, LLC. (US)
  • Seegene Inc. (South Korea)
  • Bio-Rad Laboratories, Inc. (US)
  • Charles River Laboratories, Inc. (US)
  • Olink (Sweden)
  • ASURAGEN, INC. (US)
  • Invivoscribe, Inc. (US)
  • Creative Biolabs (US)
  • ReachBio LLC (US)
  • NMI Technologietransfer GmbH (Germany)

“The consumables segment accounted for the highest growth rate in the immuno-oncology assays market, by product& service, during the forecast period”

The immuno-oncology assays market is segmented into consumables, instruments, and software & services based on product & service. In 2020, the consumables segment accounted for the highest growth rate in the immuno-oncology assays market. The requirement of consumables in large numbers as compared to instruments is the major factor contributing to the growth of this segment.

“Research applications segment accounted for the highest CAGR”

Based on application, the immuno-oncology assays market is segmented into research applications and clinical diagnostics. In 2020, the research applications segment accounted for the highest growth rate. This can be attributed to the rising prominence of biomarker-based drug development.

“Asia Pacific: The fastest-growing region immuno-oncology assays market”

The global immuno-oncology assays market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Growth in this region is expected to be centered on China and Japan. Factors such as the growing number of CROs in the region and the increasing awareness about the early detection of cancer are driving the growth of the immuno-oncology assays market in this region.

The primary interviews conducted for this report can be categorized as follows: 

  • By Company Type: Tier 1 – 40%, Tier 2 – 30%,and Tier 3 -30%
  • By Designation: C-level – 27%, D-level – 18%, and Others – 55%
  • By Region: North America -51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and the Middle East & Africa – 4%

Research Coverage:

This report provides a detailed picture of the global immuno-oncology assays market. It aims at estimating the size and future growth potential of the market across different segments, such as product& service, technology, indication, application, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall immuno-oncology assays market and its sub segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

Enquire Here for, Report Enquiry, Discount and Customization @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1943305

Table Of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.2.2 Markets Covered
Figure 1 Immuno-Oncology Assays Market Segmentation
1.2.3 Years Considered For The Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders
1.6 Summary Of Changes

2 Research Methodology
2.1 Research Data
2.2 Research Approach
Figure 2 Immuno-Oncology Assays Market: Research Design
2.2.1 Secondary Data
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Data
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Industry Insights
Figure 3 Breakdown Of Primary Interviews: By Company Type, Designation, And Region
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
Figure 4 Immuno-Oncology Assays Market: Bottom-Up Approach
Figure 5 Cagr Projections: Supply-Side Analysis
2.3.2 Top-Down Approach
Figure 6 Immuno-Oncology Assays Market: Top-Down Approach
2.4 Market Breakdown & Data Triangulation
Figure 7 Data Triangulation Methodology
2.5 Assumptions For The Study
2.6 Covid-19 Health Assessment
2.7 Covid-19 Economic Assessment
2.8 Assessment Of The Impact Of Covid-19 On The Economic Scenario
Figure 8 Criteria Impacting The Global Economy
Figure 9 Recovery Scenario Of The Global Economy
2.9 Assessment Of The Impact Of Covid-19 On The Immuno-Oncology Assays Market

3 Executive Summary
Figure 10 Immuno-Oncology Assays Market, By Product & Service, 2021 Vs. 2026 (Usd Million)
Figure 11 Immuno-Oncology Assays Market, By Technology, 2021 Vs. 2026 (Usd Million)
Figure 12 Immuno-Oncology Assays Market, By Indication, 2021 Vs. 2026 (Usd Million)
Figure 13 Immuno-Oncology Assays Market, By Application, 2021 Vs. 2026 (Usd Million)
Figure 14 Immuno-Oncology Assays Market, By Region, 2021 Vs. 2026 (Usd Million)

4 Premium Insights
4.1 Immuno-Oncology Assays Market Overview
Figure 15 Rising Prevalence Of Cancer To Drive Market Growth
4.2 Immuno-Oncology Assays Market Share, By Product & Service, 2021 Vs. 2026
Figure 16 Consumables Segment Will Continue To Dominate The Market In 2026
4.3 Immuno-Oncology Assays Market Share, By Technology, 2021 Vs. 2026
Figure 17 Ngs Segment To Gain Market Share Between 2021 And 2026
4.4 Immuno-Oncology Assays Market Share, By Indication, 2021 Vs. 2026
Figure 18 Lung Cancer Segment To Register The Highest Growth Rate During The Forecast Period
4.5 Immuno-Oncology Assays Market Share, By Application, 2021 Vs. 2026
Figure 19 Research Applications Segment Will Continue To Dominate The Market In 2026
4.6 Immuno-Oncology Assays Market: Geographic Growth Opportunities
Figure 20 Asia Pacific To Register The Highest Growth Rate In The Immuno-Oncology Assays Market During The Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 21 Immuno-Oncology Assays Market: Drivers, Restraints, Opportunities, And Challenges
5.2.1 Drivers
5.2.1.1 Rising Incidence Of Cancer And Growing Adoption Of Targeted Therapies
Table 1 Global Cancer Incidence, By Country, 2018 Vs. 2025
Table 2 Projected Increase In The Global Number Of Cancer Patients, 2015 Vs. 2018 Vs. 2035
Table 3 Research Funding For National Cancer Institute, 2016 Vs. 2017 Vs. 2018 (Usd Million)
5.2.1.2 Increased Demand For Personalized Medicine
Table 4 Growth In Fda Personalized Medicine Approval Rate, 2005–2018
5.2.2 Restraints
5.2.2.1 Requirement Of High Capital Investments And Low Cost-Benefit Ratio
5.2.2.2 Unfavorable Regulatory And Reimbursement Scenario
5.2.2.3 High Cost Of Immunotherapy
Table 5 Cost Of Keytruda, By Country (2018)
5.2.3 Opportunities
5.2.3.1 Emerging Markets Offer Lucrative Opportunities
5.2.3.2 Growing Significance Of Companion Diagnostics
5.2.4 Challenges
5.2.4.1 Low Awareness Of Cancer Immunotherapy
5.3 Impact Of Covid-19 On The Immuno-Oncology Assays Market
5.4 Pricing Analysis
Table 6 Price Of Immuno-Oncology Assays (2021)
5.5 Patent Analysis
5.6 Trade Analysis
5.6.1 Trade Analysis For Diagnostic And Laboratory Reagents
Table 7 Import Data For Diagnostic And Laboratory Reagents, By Country, 2016–2020 (Usd Million)
Table 8 Import Data For Diagnostic And Laboratory Reagents, By Country, 2016–2020 (Tons)
5.7 Value Chain Analysis
Figure 22 Major Value Is Added During The Manufacturing & Assembly Phase
5.8 Supply Chain Analysis
Figure 23 Distribution—A Strategy Preferred By Prominent Companies
5.9 Ecosystem Analysis Of The Immuno-Oncology Assays Market
Figure 24 Immuno-Oncology Assays Market: Ecosystem Analysis
5.10 Porter’s Five Forces Analysis
Table 9 Immuno-Oncology Assays Market: Porter’s Five Forces Analysis
5.10.1 Threat Of New Entrants
5.10.2 Threat Of Substitutes
5.10.3 Bargaining Power Of Buyers
5.10.4 Bargaining Power Of Suppliers
5.10.5 Degree Of Competition
5.11 Pestle Analysis
5.12 Regulatory Landscape
5.12.1 North America
5.12.1.1 Us
5.12.1.2 Canada
5.12.2 Europe
5.12.3 Asia Pacific
5.12.3.1 Japan
5.12.3.2 India
5.12.4 Latin America
5.12.4.1 Brazil
5.12.4.2 Mexico
5.12.5 Middle East
5.12.6 Africa
5.13 Technology Analysis
5.14 Yc-Ycc Shift
5.14.1 Yc-Ycc Shift For The Immuno-Oncology Assays Market

6 Immuno-Oncology Assays Market, By Product & Service
6.1 Introduction
Table 10 Immuno-Oncology Assays Market, By Product & Service, 2019–2026 (Usd Million)
6.2 Consumables
6.2.1 Recurrent Purchase Of Kits Is A Major Factor Driving Market Growth
Table 11 Key Products In The Consumables Market
Table 12 Immuno-Oncology Assays Market For Consumables, By Region, 2019–2026 (Usd Million)
6.3 Instruments
6.3.1 Launch Of Technologically Advanced Products To Support Market Growth
Table 13 Key Products In The Instruments Market
Table 14 Immuno-Oncology Assays Market For Instruments, By Region, 2019–2026 (Usd Million)
6.4 Software & Services
6.4.1 Increasing Need To Deliver Accurate And Timely Analysis Of Diagnostic Tests To Support Market Growth
Table 15 Immuno-Oncology Assays Market For Software & Services, By Region, 2019–2026 (Usd Million)

7 Immuno-Oncology Assays Market, By Technology
7.1 Introduction
Table 16 Immuno-Oncology Assays Market, By Technology, 2019–2026 (Usd Million)
7.2 Polymerase Chain Reaction
7.2.1 Emergence Of Advanced Pcr Technologies To Support Market Growth
Table 17 Immuno-Oncology Assays Market For Polymerase Chain Reaction, By Region, 2019–2026 (Usd Million)
7.3 Immunoassay
7.3.1 Immunoassays Have The Potential To Reduce Cancer Mortality Rate By Facilitating The Diagnosis Of Cancer At An Early Stage
Table 18 Immuno-Oncology Assays Market For Immunoassay, By Region, 2019–2026 (Usd Million)
7.4 Next-Generation Sequencing
7.4.1 Ngs Segment To Grow At The Highest Cagr During The Forecast Period
Table 19 Immuno-Oncology Assays Market For Next-Generation Sequencing, By Region, 2019–2026 (Usd Million)
7.5 In Situ Hybridization
7.5.1 High Demand For In Situ Hybridization In The Diagnosis Of Small Tumors To Drive Market Growth
Table 20 Immuno-Oncology Assays Market For In Situ Hybridization, By Region, 2019–2026 (Usd Million)
7.6 Flow Cytometry
7.6.1 Growing Incidence & Prevalence Of Cancer To Support Market Growth
Table 21 Immuno-Oncology Assays Market For Flow Cytometry, By Region, 2019–2026 (Usd Million)

8 Immuno-Oncology Assays Market, By Indication

Read More…………….

Get Discount on the Latest Report @ https://www.reportsnreports.com/contacts/discount.aspx?name=1943305

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact Us:

Corporate Headquarters

Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India

 + 1 888 391 5441
 [email protected]

Share This Post